⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Cell and Gene Therapy Investment Trends Strategic Intelligence Report 2025-2031: Yescarta from Gilead Sciences and Zolgensma from Novartis Generated $1.5 Billion and $1.2 Billion in 2024 Sales
globenewswire.com
GILD
JNJ
SRPT
Global Neurovascular Devices Market Set to Grow Steadily at a CAGR of ~8% by 2032 | DelveInsight
globenewswire.com
MDT
SYK
PEN
JNJ
BSX
TLF
LPSN
Global Tumor Ablation Market Set to Reach USD 1.4 Billion by 2029 | MarketsandMarkets™
globenewswire.com
JNJ
MDT
SYK
VRTX
ANGI
BSX
BVS
Harvest lance six FNB d'actions à revenu élevé améliorés, se positionnant comme chef de file du secteur à la Bourse de Toronto (TSX)
businesswire.com
CRWD
JNJ
JPM
ORCL
Harvest Introduces Six Enhanced High‑Income Shares ETFs, Setting Sector Leadership on the TSX
businesswire.com
CRWD
JNJ
JPM
ORCL
Left Atrial Appendage Closure Devices Market 2025-2033: Demand Forecast, Regional Insights, Company Profiles – Astute Analytica
globenewswire.com
WMT
JNJ
MD
TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide
prnewswire.com
JNJ
OBE Launches Onboard Sports Advisory with Former Team USA and LA28 Commercial Executives
businesswire.com
JPM
META
NKE
SBUX
NVDA
CMCSA
DAL
AMZN
MCD
PEP
SIRI
JNJ
GOOGL
CON
BD Names Shawn Bevec as Senior Vice President of Investor Relations
prnewswire.com
BDX
DGX
DB
SI
PFE
JNJ
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
NVS
BIIB
VTRS
UCB
BMY
ABBV
REGN
SNY
LLY
JNJ
HOPE
GCBC
AMGN
TAK